These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 17950886)

  • 1. The role of small molecule inhibitors for veterinary patients.
    London CA
    Vet Clin North Am Small Anim Pract; 2007 Nov; 37(6):1121-36; vii. PubMed ID: 17950886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targets for cancer therapy in childhood sarcomas.
    Wachtel M; Schäfer BW
    Cancer Treat Rev; 2010 Jun; 36(4):318-27. PubMed ID: 20223596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel small-molecule therapy of Hodgkin lymphoma.
    Buglio D; Georgakis G; Younes A
    Expert Rev Anticancer Ther; 2007 May; 7(5):735-40. PubMed ID: 17492936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid cancer molecular signaling pathways and use of targeted therapy.
    Kundra P; Burman KD
    Endocrinol Metab Clin North Am; 2007 Sep; 36(3):839-53, viii. PubMed ID: 17673131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MS-275, a novel histone deacetylase inhibitor with selectivity against HDAC1, induces degradation of FLT3 via inhibition of chaperone function of heat shock protein 90 in AML cells.
    Nishioka C; Ikezoe T; Yang J; Takeuchi S; Koeffler HP; Yokoyama A
    Leuk Res; 2008 Sep; 32(9):1382-92. PubMed ID: 18394702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-protein interactions as targets for small-molecule therapeutics in cancer.
    White AW; Westwell AD; Brahemi G
    Expert Rev Mol Med; 2008 Mar; 10():e8. PubMed ID: 18353193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule signal transduction inhibitors for the treatment of solid tumors.
    Leary A; Johnston SR
    Cancer Invest; 2007 Aug; 25(5):347-65. PubMed ID: 17661211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond monoclonal antibodies: new therapeutic agents in non-Hodgkin's lymphomas.
    Delmonte A; Ghielmini M; Sessa C
    Oncologist; 2009 May; 14(5):511-25. PubMed ID: 19411316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Therapies in Veterinary Oncology.
    Londhe P; Gutwillig M; London C
    Vet Clin North Am Small Anim Pract; 2019 Sep; 49(5):917-931. PubMed ID: 31186124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule inhibitors in children with malignant gliomas.
    Herrington B; Kieran MW
    Pediatr Blood Cancer; 2009 Sep; 53(3):312-7. PubMed ID: 19434732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cancer invasion and metastasis by targeting the molecular chaperone heat-shock protein 90.
    Koga F; Kihara K; Neckers L
    Anticancer Res; 2009 Mar; 29(3):797-807. PubMed ID: 19414312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biological diversity of protein lysine acetylation which has been revealed by small molecule inhibitors].
    Shimazu T; Horinouchi S; Yoshida M
    Tanpakushitsu Kakusan Koso; 2007 Oct; 52(13 Suppl):1751-7. PubMed ID: 18051411
    [No Abstract]   [Full Text] [Related]  

  • 13. Drugging the cancer kinome: progress and challenges in developing personalized molecular cancer therapeutics.
    Workman P
    Cold Spring Harb Symp Quant Biol; 2005; 70():499-515. PubMed ID: 16869789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat-shock protein 90 (Hsp90) as a molecular target for therapy of gastrointestinal cancer.
    Moser C; Lang SA; Stoeltzing O
    Anticancer Res; 2009 Jun; 29(6):2031-42. PubMed ID: 19528462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDACi--targets beyond chromatin.
    Buchwald M; Krämer OH; Heinzel T
    Cancer Lett; 2009 Aug; 280(2):160-7. PubMed ID: 19342155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic application of histone deacetylase inhibitors for central nervous system disorders.
    Kazantsev AG; Thompson LM
    Nat Rev Drug Discov; 2008 Oct; 7(10):854-68. PubMed ID: 18827828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AACR-NCI-EORTC--19th symposium. Molecular Targets and Cancer Therapeutics--Part 2.
    Searle B; Collins T
    IDrugs; 2007 Dec; 10(12):836-9. PubMed ID: 18041674
    [No Abstract]   [Full Text] [Related]  

  • 18. Discovery of benzisoxazoles as potent inhibitors of chaperone heat shock protein 90.
    Gopalsamy A; Shi M; Golas J; Vogan E; Jacob J; Johnson M; Lee F; Nilakantan R; Petersen R; Svenson K; Chopra R; Tam MS; Wen Y; Ellingboe J; Arndt K; Boschelli F
    J Med Chem; 2008 Feb; 51(3):373-5. PubMed ID: 18197612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation.
    Fionda C; Soriani A; Malgarini G; Iannitto ML; Santoni A; Cippitelli M
    J Immunol; 2009 Oct; 183(7):4385-94. PubMed ID: 19748980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine kinase inhibitors in veterinary medicine.
    London CA
    Top Companion Anim Med; 2009 Aug; 24(3):106-12. PubMed ID: 19732728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.